Cardia Bioplastics Limited (CNN) is pleased to announce a new partner ship with Alto Packaging to innovate and deliver high performance packaging solutions with an improved environmental profile to the food industry. The alliance with Alto Packaging, one of the leading rigid plastic packaging companies in Australasia, is a milestone achievement for Cardia that creates significant future growth opportunities for the Company.
As part of the agreement, Cardia will provide the renewable resins to form the basis of Alto Packaging’s environmentally-friendly packaging systems. The supply agreement will initially focus on Alto’s fresh food range, friendly The but has the real potential to expand into other Alto Packaging product channels in the future. Through 62 years of operation, Alto Packaging has established an expansive footprint of customers across to Australasia – a customer base that Cardia will now benefit from. This existing sales platform is expected to quickly and significantly increase the Company’s sales revenue. This major alliance, with a leading Australasian packaging supplier, is a strong indicator of Cardia’s future growth supplier, potential. As the global shift towards greener economies intensifies, Cardia’s range of patented renewable resin technologies will play a key future role in reducing the carbon footprint of the plastics a packaging industries.
Managing Director, Dr Frank Glatz, commented: “This strategic alliance with Alto Food Packaging is further validation of Cardia’s unique patented technology and provides the Company with an extensive network of relationships with leading suppliers in the food industry. Our sales pipeline will grow substantially as we work in collaboration with Alto Packaging to produce high performance packaging solutions with an improved carbon footprint.” “This is an exciting time for Cardia as the growth in our portfolio of major contracts continues to build momentum. The bioplastics industry is growing globally, tracking double digit growth and Cardia is well positioned to capitalise on this emerging market.”
www.cardiabioplastics.com
